Matthew Spear, M.D.

Matthew Spear, M.D. has a long and varied career in the medical field. From 1991 to 2004, they worked in Research & Development at Pfizer Pharmaceuticals. In 2004, they moved to Oncology at Pfizer Pharmaceuticals. From 2005 to 2010, they were the Chief Medical Officer and Senior Vice President at Nereus Pharmaceuticals. From 2010 to 2012, they were an Associate Professor at the USC Keck School of Medicine. From 2012 to 2014, they were the Head of Oncology and Head of Biotherapeutics at Sunovion Pharmaceuticals Inc. From 2014 to 2016, they were the VP Clinical Development at Incyte. From 2016 to 2022, they were the Chief Medical Officer at Poseida Therapeutics, Inc. Currently, they are the Chief Development Officer and Chief Medical Officer at Denovo Biopharma.

Matthew Spear, M.D. received their M.D. from Stanford University School of Medicine in 1993. From 1994 to 1998, they were a Resident/Fellow at Massachusetts General Hospital/Harvard Medical School. Prior to that, they received their B.A. in Biology from The Johns Hopkins University in 1988.